Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea's Health Ministry Gets In The Act To Generate Korean Innovation For U.S. Markets

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korea's Ministry of Health and Welfare has selected 21 Korean pharmaceutical manufacturers and 17 medical equipment firms to support these companies in the development of globally competitive new drugs, marketing efforts and U.S. FDA approvals needed for their advancement into the U.S. market
Advertisement

Related Content

Korea’s Boryung Licenses Hypertension Therapy Kanarb To China’s Harbin Gloria
Korea’s KHIDI Mobilizes Pharma Experts To Help Korean Pharma Go Global
Korea's Ilyang Pharmaceutical Starts Phase III Trials For First-line CML Drug To Compete With Gleevec
Korea Tries To Buffer Heavy Price Cuts With R&D Incentives, But Local And Global Pharma Up In Arms
Korea Tries To Buffer Heavy Price Cuts With R&D Incentives, But Local And Global Pharma Up In Arms
Korea And U.S. Health Ministers Agree To Enhance Cooperation In Anticipation Of Increased Pharma, Device Trade
Korea's CrystalGenomics Evaluates Phase II Options For Super Bug Antibiotic Candidate
Korea Biosimilar Play LG Life Sciences Names New CEO Amid Unfriendly Business Conditions
Korea Biosimilar Play LG Life Sciences Names New CEO Amid Unfriendly Business Conditions
Korean Government Announces Joint Fund To Beef Up Local Pharma Industry
Advertisement
UsernamePublicRestriction

Register

SC077600

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel